Flibanserin (Addyi)
Flibanserin is the first FDA approved medication designed to treat hypoactive sexual desire disorder (HSDD) in perimenopause.
How flibanserin works
Flibanserin is a non-hormonal medication that affects the balance of brain chemicals, serotonin and dopamine, which are associated with sexual desire and inhibition. This only works for women who lost their sexual desire because of perimenopause or menopause.
Potential benefits of flibanserin for menopause
- Improvement in sexual desire
- Helps with psychological well-being